You are here:  

• Print

Skin of Colour Resource

 

Melasma

 

 

Efficacy and Safety of Low Fluence Nd:YAG Laser Treatment in Melasma: A Meta-Analysis and Systematic Review. Cervantes J, Patzelt N, Al-Janahi S, Kim DH, Chung HJ.  Dermatol Surg. 2023 Jan 1;49(1):36-41. doi: 10.1097/DSS.0000000000003635. Epub 2022 Nov 28. PMID: 36533794. Systematic Review. 

Efficacy and safety of topical agents in the treatment of melasma: What's evidence? A systematic review and meta-analysis.  Chang YF, Lee TL, Oyerinde O, Desai SR, Aljabban A, Bay CP, Bain PA, Chung HJ.  J Cosmet Dermatol. 2023 Apr;22(4):1168-1176. doi: 10.1111/jocd.15566. Epub 2022 Dec 25. PMID: 36566490. Systematic Review. 

Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis. Feng J, Shen S, Song X, Xiang W. Lasers Med Sci. 2023 Mar 10;38(1):84. doi: 10.1007/s10103-023-03744-y. PMID: 36897459. Systematic Review. 

Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus.  Desai S, Chan L, Handog E, Djojoseputro L, Lim J, Ling R, Nguyen H, Tam E, Tang J, Thng S, Tran H. J Drugs Dermatol. 2023 Apr 1;22(4):386-392. doi: 10.36849/JDD.7104. PMID: 37026889. Systematic Review.  

Efficacy of topical vitamin C in melasma and photoaging: A systematic review. Correia G, Magina S. J Cosmet Dermatol. 2023 Jul;22(7):1938-1945. doi: 10.1111/jocd.15748. Epub 2023 May 2. PMID: 37128827. Systematic Review. 

Effectiveness of laser and topical tranexamic acid combination therapy in melasma: An updated systematic review and meta-analysis of randomized controlled trials. Khan QA, Abdi P, Farkouh C, Anthony MR, Chundru A, Amatul F, Parimi K, Santiago N, Farkouh M, Iram S, Khan A.  Lasers Med Sci. 2023 Jun 16;38(1):139. doi: 10.1007/s10103-023-03810-5. PMID: 37326860. Systematic Review. 

Efficacy and Safety of Picosecond Laser in the Treatment of Melasma: A Network Meta-analysis. Ren R, Bao S, Qian W, Zhao H.Dermatol Surg. 2023 May 1;49(5S):S49-S55. doi: 10.1097/DSS.0000000000003775. Epub 2023 Apr 11. PMID: 37116000. Meta-analysis.

Efficacy and safety of laser-assisted delivery of tranexamic acid for the treatment of melasma: a systematic review and meta analysis.  Feng J, Shen S, Song X, Xiang W.  J Cosmet Laser Ther. 2022 Nov 17;24(6-8):73-79. doi: 10.1080/14764172.2022.2148186. Epub 2022 Nov 20. PMID: 36403155.  Systematic review.

The optimal dose of oral tranexamic acid in melasma: A network meta-analysis.  Wang WJ, Wu TY, Tu YK, Kuo KL, Tsai CY, Chie WC.  Indian J Dermatol Venereol Leprol. 2023 Jan-Mar;89(2):189-194. doi: 10.25259/IJDVL_530_2021. PMID: 36332095. Meta-analysis. 

Is cysteamine use effective in the treatment of melasma? A systematic review and meta-analysis. Dos Santos-Neto AG, da Silva ÍCV, Melo CR, Santana AAM, de Albuquerque-Junior RLC.  Dermatol Ther. 2022 Dec;35(12):e15961. doi: 10.1111/dth.15961. Epub 2022 Nov 2. PMID: 36285354. Systematic Review.  

Microneedling with cutaneous delivery of topical agents for the treatment of melasma: A systematic review.  Brasil Dos Santos J, Nagem Lopes LP, de Lima GG, Teixeira da Silva R, da Silva E Souza Lorca B, Miranda Pinheiro G, Faria de Freitas ZM.  J Cosmet Dermatol. 2022 Nov;21(11):5680-5695. doi: 10.1111/jocd.15287. Epub 2022 Sep 25. PMID: 35933690. Systematic Review. 

The Low-Fluence Q-Switched Nd:YAG Laser Treatment for Melasma: A Systematic Review. Lee YS, Lee YJ, Lee JM, Han TY, Lee JH, Choi JE. Medicina (Kaunas). 2022 Jul 14;58(7):936. doi: 10.3390/medicina58070936. PMID: 35888655; PMCID: PMC9323185. Systematic Review. 

Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials. Pennitz A, Kinberger M, Avila Valle G, Passeron T, Nast A, Werner RN. Br J Dermatol. 2022 Sep;187(3):309-317. doi: 10.1111/bjd.21244. Epub 2022 May 18. PMID: 35290681. Systematic Review. 

Single and combined 1064 nm Q-switched Nd: YAG laser therapy in melasma: A meta-analysis. Zhang B, Xie B, Shen Y, Zhang L, Song X. J Cosmet Dermatol. 2022 Sep;21(9):3794-3802. doi: 10.1111/jocd.15270. Epub 2022 Sep 5. PMID: 35876484. Meta-analysis. 

Topical Treatments for Melasma and Their Mechanism of Action. González-Molina V, Martí-Pineda A, González N.  J Clin Aesthet Dermatol. 2022 May;15(5):19-28. PMID: 35642229; PMCID: PMC9122278. Review.

Comparison of the Efficacy of Melasma Treatments: A Network Meta-Analysis of Randomized Controlled Trials. Liu Y, Wu S, Wu H, Liang X, Guo D, Zhuo F. Front Med (Lausanne). 2021 Sep 29;8:713554. doi: 10.3389/fmed.2021.713554. eCollection 2021. PMID: 34660626 Free PMC article.

Correlation of Oxidative Stress with Melasma: An Overview. Katiyar S, Yadav D. Curr Pharm Des. 2021 Nov 4. doi: 10.2174/1381612827666211104154928. Online ahead of print. PMID: 34736377

Efficacy and Safety of Oral Herbal Drugs Used as Adjunctive Therapy for Melasma: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Tang Q, Yang H, Liu X, Zou Y, Lv X, Chen K. Evid Based Complement Alternat Med. 2021 Dec 6;2021:9628319. doi: 10.1155/2021/9628319. eCollection 2021. PMID: 34912468 Free PMC article. Review.

Platelet-Rich Plasma in Melasma-A Systematic Review. Sarkar R, Gupta M. Dermatol Surg. 2022 Jan 1;48(1):131-134. doi: 10.1097/DSS.0000000000003266.  PMID: 34904579

Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review. Ahramiyanpour N, Saki N, Akbari Z, Shamsi-Meymandi S, Amiri R, Heiran A. J Cosmet Dermatol. 2021 Nov;20(11):3593-3602. doi: 10.1111/jocd.14494. Epub 2021 Sep 30. PMID: 34591360 Review.

 The pathogenesis of melasma and implications for treatment. Artzi O, Horovitz T, Bar-Ilan E, Shehadeh W, Koren A, Zusmanovitch L, Mehrabi JN, Salameh F, Isman Nelkenbaum G, Zur E, Sprecher E, Mashiah J. J Cosmet Dermatol. 2021 Nov;20(11):3432-3445. doi: 10.1111/jocd.14382. Epub 2021 Aug 19. PMID: 34411403 Review.

Safety and efficacy of mesotherapy in the treatment of melasma: A review article. Khalili M, Amiri R, Iranmanesh B, Zartab H, Aflatoonian M. J Cosmet Dermatol. 2021 Nov 30. doi: 10.1111/jocd.14644. Online ahead of print. PMID: 34846788 Review.

Natural Cosmeceutical Ingredients for the Management of Hyperpigmentation in Hispanic and Latino Women. Murphy MJ, Dow AA. J Clin Aesthet Dermatol. 2021 Aug;14(8):52-56. Epub 2021 Aug 1. PMID: 34840659 Free PMC article. Review.

Microneedling as an adjuvant to topical therapies for melasma: A systematic review and meta-analysis. Michel Bailey AJ, Oi-Yee Li H, Tan MG, Cheng W, Dover JS. J Am Acad Dermatol. 2021 Apr 12:S0190-9622(21)00767-2. doi: 10.1016/j.jaad.2021.03.116. Online ahead of print. PMID: 33857549

Melasma treatment: a systematic review. Neagu N, Conforti C, Agozzino M, Marangi GF, Morariu SH, Pellacani G, Persichetti P, Piccolo D, Segreto F, Zalaudek I, Dianzani C. J Dermatolog Treat. 2021 Apr 14:1-39. doi: 10.1080/09546634.2021.1914313. Online ahead of print. PMID: 33849384

A review of combined treatments for melasma involving energy-based devices and proposed pathogenesis-oriented combinations. Mehrabi JN, Bar-Ilan E, Wasim S, Koren A, Zusmanovitch L, Salameh F, Isman Nelkenbaum G, Horovitz T, Zur E, Song Lim T, Mashiah J, Artzi O. J Cosmet Dermatol. 2021 Apr 1. doi: 10.1111/jocd.14110. Online ahead of print. PMID: 33794033 Review.

Are improvements in melasma severity correlated with improvements in quality of life? A systematic review. Bailey AMJ, Dorus B, Li HO, Kanigsberg N. Dermatol Ther. 2021 May 30:e15011. doi: 10.1111/dth.15011. Online ahead of print. PMID: 34053172 No abstract available.

Platelet rich plasma is a promising therapy for melasma. Tuknayat A, Bhalla M, Pal Thami G. J Cosmet Dermatol. 2021 May 19. doi: 10.1111/jocd.14229. Online ahead of print. PMID: 34013618 Review.

Efficacy and tolerability of chemical peeling as a single agent for melasma in dark-skinned patients: A systematic review and meta-analysis of comparative trials. Dorgham NA, Hegazy RA, Sharobim AK, Dorgham DA. J Cosmet Dermatol. 2020 Nov;19(11):2812-2819. doi: 10.1111/jocd.13725. Epub 2020 Sep 29. PMID: 32947652 

The Therapeutic Use of Antioxidants for Melasma. Babbush KM, Babbush RA, Khachemoune A. J Drugs Dermatol. 2020 Aug 1;19(8):788-792. doi: 10.36849/JDD.2020.5079. PMID: 32845595 Review.

Treatment of melasma: a review of less commonly used antioxidants. Babbush KM, Babbush RA, Khachemoune A. Int J Dermatol. 2021 Feb;60(2):166-173. doi: 10.1111/ijd.15133. Epub 2020 Aug 20. PMID: 32815582 Review.

 Efficacy and Safety of Platelet-Rich Plasma in Melasma: A Systematic Review and Meta-Analysis. Zhao L, Hu M, Xiao Q, Zhou R, Li Y, Xiong L, Li L. Dermatol Ther (Heidelb). 2021 Jul 16. doi: 10.1007/s13555-021-00575-z. Online ahead of print. PMID: 34269967

Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review. Ahramiyanpour N, Saki N, Akbari Z, Shamsi-Meymandi S, Amiri R, Heiran A. J Cosmet Dermatol. 2021 Sep 30. doi: 10.1111/jocd.14494. Online ahead of print. PMID: 34591360 Review.

The Application of Skin Care Product in Melasma Treatment. Wang Y, Zhao J, Jiang L, Mu Y. Clin Cosmet Investig Dermatol. 2021 Sep 7;14:1165-1171. doi: 10.2147/CCID.S323748. eCollection 2021. PMID: 34526794 Free PMC article. Review.

An Herbal H2 Blocker in Melasma Treatment. Mahjour M, Khoushabi A. Curr Drug Discov Technol. 2020;17(3):272-277. doi: 10.2174/1570163816666190121145653. PMID: 30666910 Review.

The efficacy of energy-based devices combination therapy for melasma. Iranmanesh B, Khalili M, Mohammadi S, Amiri R, Aflatoonian M.Dermatol Ther. 2021 Mar 4:e14927. doi: 10.1111/dth.14927. Online ahead of print.PMID: 33665885 Review.

The vascular component of melasma: A systematic review of laboratory, diagnostic, and therapeutic evidence.
Masub N, Nguyen JK, Austin E, Jagdeo J.
Dermatol Surg. 2020 Dec;46(12):1642-1650. doi: 10.1097/DSS.0000000000002770. Systematic review.

Efficacy and tolerability of chemical peeling as a single agent for melasma in dark-skinned patients: A systematic review and meta-analysis of comparative trials.
Dorgham NA, Hegazy RA, Sharobim AK, Dorgham DA.
J Cosmet Dermatol. 2020 Sep 18. doi: 10.1111/jocd.13725. Online ahead of print. Systematic review.

A systematic review of the efficacy and safety of microneedling in the treatment of melasma.
Wu SZ, Muddasani S, Alam M.
Dermatol Surg. 2020 Sep 2. doi: 10.1097/DSS.0000000000002763. Online ahead of print. Systematic review.

A meta-analysis-based assessment of intense pulsed light for treatment of melasma.
Yi J, Hong T, Zeng H, Li P, Li P, Wang S, Chen J, Li P, Zhou J.
Aesthetic Plast Surg. 2020 Feb 13. doi: 10.1007/s00266-020-01637-x. [Epub ahead of print]. Systematic review.

Melasma treatment: An evidence-based review.
McKesey J, Tovar-Garza A, Pandya AG.
Am J Clin Dermatol. 2019 Dec 4. doi: 10.1007/s40257-019-00488-w. [Epub ahead of print]. Systematic review.

Topical treatments for melasma: A systematic review of randomized controlled trials.
Austin E, Nguyen JK, Jagdeo J.
J Drugs Dermatol. 2019 Nov 1;18(11). pii: S1545961619P1156X. Systematic review.

Laser and laser compound therapy for melasma: A meta-analysis.
Zhang Y, Zheng X, Chen Z, Lu L.
J Dermatolog Treat. 2019 Jan 31:1-19. doi: 10.1080/09546634.2019.1577544. [Epub ahead of print]. Systematic review.

Tranexamic acid for adults with melasma: a systematic review and meta-analysis.
Zhang L, Tan WQ, Fang QQ, Zhao WY, Zhao QM, Gao J, Wang XW.
Biomed Res Int. 2018 Nov 6;2018:1683414. doi: 10.1155/2018/1683414. eCollection 2018. Systematic review.

Evaluation instruments for quality of life related to melasma: An integrative review.
Pollo CF, Meneguin S, Miot HA.
Clinics (Sao Paulo). 2018 May 21;73:e65. doi: 10.6061/clinics/2018/e65.  Systematic review.

Efficacy and safety of tranexamic acid in melasma: A meta-analysis and systematic review.
Kim HJ, Moon SH, Cho SH, Lee JD, Kim HS.
Acta Derm Venereol. 2017 Jul 6;97(7):776-781. doi: 10.2340/00015555-2668. Systematic review.

Melasma: systematic review of the systemic treatments.
Zhou LL, Baibergenova A.
Int J Dermatol. 2017 Sep;56(9):902-908. doi: 10.1111/ijd.13578. Epub 2017 Feb 27. Systematic review.

Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
Taraz M, Niknam S, Ehsani AH.
Dermatol Ther. 2017 May;30(3). doi: 10.1111/dth.12465. Epub 2017 Jan 30. Systematic review.

Fractional resurfacing in the Asian patient: Current state of the art.
Wat H, Wu DC, Chan HH.
Lasers Surg Med. 2017 Jan;49(1):45-59. doi: 10.1002/lsm.22579. Epub 2016 Sep 8. Systematic review.

Acupuncture for melasma in women: a systematic review of randomised controlled trials.
Chai Q, Fei Y, Cao H, Wang C, Tian J, Liu J.
Acupunct Med. 2015 Aug;33(4):254-61. doi: 10.1136/acupmed-2014-010633. Epub 2015 Apr 21. Systematic review. 

Evidence-based treatment for melasma: expert opinion and a review. 
Shankar K, Godse K, Aurangabadkar S, Lahiri K, Mysore V, Ganjoo A, Vedamurty M, Kohli M, Sharad J, Kadhe G, Ahirrao P, Narayanan V, Motlekar SA.
Dermatol Ther (Heidelb). 2014 Dec;4(2):165-86. doi: 10.1007/s13555-014-0064-z. Epub 2014 Oct 1. Systematic review.

Melasma and laser treatment: an evidenced-based analysis. 
Halachmi S, Haedersdal M, Lapidoth M.
Lasers Med Sci. 2014 Mar;29(2):589-98. doi: 10.1007/s10103-013-1318-1. Epub 2013 Jun 14. Systematic review.

Systematic review of randomized controlled trials on interventions for melasma: an abridged Cochrane review. 
Jutley GS, Rajaratnam R, Halpern J, Salim A, Emmett C.
J Am Acad Dermatol. 2014 Feb;70(2):369-73. doi: 10.1016/j.jaad.2013.07.044. Systematic review.

Treatment of melasma with topical agents, peels and lasers: an evidence-based review. 
Rivas S, Pandya AG.
Am J Clin Dermatol. 2013 Oct;14(5):359-76. doi: 10.1007/s40257-013-0038-4. Systematic review.

Interventions for melasma. 
Rajaratnam R, Halpern J, Salim A, Emmett C.
Cochrane Database Syst Rev. 2010 Jul 7;(7):CD003583. doi: 10.1002/14651858.CD003583.pub2. Systematic review.

The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review. 
Kang HY, Valerio L, Bahadoran P, Ortonne JP.
Am J Clin Dermatol. 2009;10(4):251-60. doi: 10.2165/00128071-200910040-00005. Systematic review.

[Chemical peeling for treatment of melasma, pigmentary disorders and hyperpigmentation : Indications, effectivity and risks].
Borelli C, Fischer S.
Hautarzt. 2020 Dec;71(12):950-959. doi: 10.1007/s00105-020-04712-1. German. Review.

The therapeutic use of antioxidants for melasma.
Babbush KM, Babbush RA, Khachemoune A.
J Drugs Dermatol. 2020 Aug 1;19(8):788-792. doi: 10.36849/JDD.2020.5079. Review.

Treatment of melasma: a review of less commonly used antioxidants.
Babbush KM, Babbush RA, Khachemoune A.
Int J Dermatol. 2020 Aug 20. doi: 10.1111/ijd.15133. Online ahead of print. Review.

Melasma’s impact on quality of life.
Kagha K, Fabi S, Goldman MP.
J Drugs Dermatol. 2020 Feb 1;19(2):184-187. doi: 10.36849/JDD.2020.4663. Review.

The role of sunscreen in melasma and postinflammatory hyperpigmentation.
Fatima S, Braunberger T, Mohammad TF, Kohli I, Hamzavi IH.
Indian J Dermatol. 2020 Jan-Feb;65(1):5-10. doi: 10.4103/ijd.IJD_295_18. Review.

Future therapies in melasma: What lies ahead?
Sarkar R, Bansal A, Ailawadi P.
Indian J Dermatol Venereol Leprol. 2020 Jan-Feb;86(1):8-17. doi: 10.4103/ijdvl.IJDVL_633_18. Review.

Chemical peeling for acne and melasma: current status and innovations.
Conforti C, Zalaudek I, Vezzoni R, Retrosi C, Fai A, Fadda S, Di Michele E, Dianzani C.
G Ital Dermatol Venereol. 2019 Dec 4. doi: 10.23736/S0392-0488.19.06425-3. [Epub ahead of print]. Review.

Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies.
Rajanala S, Maymone MBC, Vashi NA.
Dermatol Online J. 2019 Oct 15;25(10). pii: 13030/qt47b7r28c. Review.

Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
Spierings NMK.
J Cosmet Dermatol. 2019 Oct 11. doi: 10.1111/jocd.13182. [Epub ahead of print]. Review.

Tranexamic acid for melasma: Evaluating the various formulations.
Wang JV, Jhawar N, Saedi N.
J Clin Aesthet Dermatol. 2019 Aug;12(8):E73-E74. Epub 2019 Aug 1. Review.

Laser toning in melasma.
Shah SD, Aurangabadkar SJ.
J Cutan Aesthet Surg. 2019 Apr-Jun;12(2):76-84. doi: 10.4103/JCAS.JCAS_179_18. Review.

Therapeutic insights in melasma and hyperpigmentation management.
Huerth KA, Hassan S, Callender VD.
J Drugs Dermatol. 2019 Aug 1;18(8):718-729. Review.

What's new in pigmentary disorders.
Zubair R, Lyons AB, Vellaichamy G, Peacock A, Hamzavi I.
Dermatol Clin. 2019 Apr;37(2):175-181. doi: 10.1016/j.det.2018.12.008. Epub 2019 Feb 16. Review.

Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology.
Passeron T, Genedy R, Salah L, Fusade T, Kositratna G, Laubach HJ, Marini L, Badawi A.
J Eur Acad Dermatol Venereol. 2019 Mar 14. doi: 10.1111/jdv.15497. [Epub ahead of print]. Review.

Hyperpigmentation disorders in Hispanic population in the United States.
Rendon MI.
J Drugs Dermatol. 2019 Mar 1;18(3):s112-114. Review.

Melasma: How hormones can modulate skin pigmentation.
Filoni A, Mariano M, Cameli N.
J Cosmet Dermatol. 2019 Feb 18. doi: 10.1111/jocd.12877. [Epub ahead of print] Review.

Melasma: update on management.
Suggs AK, Hamill SS, Friedman PM.
Semin Cutan Med Surg. 2018 Dec;37(4):217-225. doi: 10.12788/j.sder.2018.049. Review.

Melasma: Updates and perspectives.
Kwon SH, Na JI, Choi JY, Park KC.
Exp Dermatol. 2018 Nov 13. doi: 10.1111/exd.13844. [Epub ahead of print]. Review. 

Oral tranexamic acid for the treatment of melasma: A review.
Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M.
Dermatol Surg. 2018 Apr 19. doi: 10.1097/DSS.0000000000001518. [Epub ahead of print]. Review.

Treatment of melasma using tranexamic acid: what's known and what's next.
Sheu SL.
Cutis. 2018 Feb;101(2):E7-E8. Review.

Melasma in men: A review of clinical, etiological, and management issues.
Sarkar R, Ailawadi P, Garg S.
J Clin Aesthet Dermatol. 2018 Feb;11(2):53-59. Epub 2018 Feb 1. Review.

Natural options for management of melasma, a review.
Nomakhosi M, Heidi A.
J Cosmet Laser Ther. 2018 Feb 20:1-12. doi: 10.1080/14764172.2018.1427874. [Epub ahead of print]. Review.

Melasma, a photoaging disorder.
Passeron T, Picardo M.
Pigment Cell Melanoma Res. 2017 Dec 29. doi: 10.1111/pcmr.12684. [Epub ahead of print] Review.

Evidence-based review, grade of recommendation, and suggested treatment recommendations for melasma.
Sarma N, Chakraborty S, Poojary SA, Rathi S, Kumaran S, Nirmal B, Felicita J, Sarkar R, Jaiswal P, D'Souza P, Donthula N, Sethi S, Ailawadi P, Joseph B.
Indian Dermatol Online J. 2017 Nov-Dec;8(6):406-442. doi: 10.4103/idoj.IDOJ_187_17. Review.

Medical management of melasma: A review with consensus recommendations by Indian pigmentary expert group.
Sarkar R, Gokhale N, Godse K, Ailawadi P, Arya L, Sarma N, Torsekar RG, Somani VK, Arora P, Majid I, Ravichandran G, Singh M, Aurangabadkar S, Arsiwala S, Sonthalia S, Salim T, Shah S.
Indian J Dermatol. 2017 Nov-Dec;62(6):558-577. doi: 10.4103/ijd.IJD_489_17. Review.

Chemical peels in melasma: A review with consensus recommendations by Indian pigmentary expert group.
Sarkar R, Arsiwala S, Dubey N, Sonthalia S, Das A, Arya L, Gokhale N, Torsekar RG, Somani VK, Majid I, Godse K, Ravichandran G, Singh M, Aurangabadkar S, Salim T, Shah S, Sinha S.
Indian J Dermatol. 2017 Nov-Dec;62(6):578-584. doi: 10.4103/ijd.IJD_490_17. Review.

Lasers in melasma: A review with consensus recommendations by Indian pigmentary expert group.
Sarkar R, Aurangabadkar S, Salim T, Das A, Shah S, Majid I, Singh M, Ravichandran G, Godse K, Arsiwala S, Arya L, Gokhale N, Sarma N, Torsekar RG, Sonthalia S, Somani VK.
Indian J Dermatol. 2017 Nov-Dec;62(6):585-590. doi: 10.4103/ijd.IJD_488_17. Review.

Melasma: an up-to-date comprehensive review.
Ogbechie-Godec OA, Elbuluk N.
Dermatol Ther (Heidelb). 2017 Sep;7(3):305-318. doi: 10.1007/s13555-017-0194-1. Epub 2017 Jul 19. Review.

Updates in the understanding and treatments of skin & hair disorders in women of color.
Lawson CN, Hollinger J, Sethi S, Rodney I, Sarkar R, Dlova N, Callender VD.
Int J Womens Dermatol. 2017 Feb 16;3(1 Suppl):S21-S37. doi: 10.1016/j.ijwd.2017.02.006. eCollection 2017 Mar. Review.

A review of laser and light therapy in melasma.
Trivedi MK, Yang FC, Cho BK.
Int J Womens Dermatol. 2017 Mar 21;3(1):11-20. doi: 10.1016/j.ijwd.2017.01.004. eCollection 2017 Mar. Review.

Tranexamic acid in the treatment of melasma: A review of the literature.
Perper M, Eber AE, Fayne R, Verne SH, Magno RJ, Cervantes J, ALharbi M, ALOmair I, Alfuraih A, Nouri K.
Am J Clin Dermatol. 2017 Jun;18(3):373-381. doi: 10.1007/s40257-017-0263-3. Review.

[Melasma : An update on the clinical picture, treatment, and prevention].
Becker S, Schiekofer C, Vogt T, Reichrath J.
Hautarzt. 2017 Feb;68(2):120-126. doi: 10.1007/s00105-016-3927-7. Review. German.

Melasma.
Lee BW, Schwartz RA, Janniger CK.
G Ital Dermatol Venereol. 2017 Feb;152(1):36-45. doi: 10.23736/S0392-0488.16.05425-0. Epub 2016 Sep 2. Review.

A review of melasma treatment focusing on laser and light devices.
Li JY, Geddes ER, Robinson DM, Friedman PM.
Semin Cutan Med Surg. 2016 Dec;35(4):223-232. doi: 10.12788/j.sder.2016.060. Review.

Facial hyperpigmentation in skin of color: Special considerations and treatment.
Vashi NA, Wirya SA, Inyang M, Kundu RV.
Am J Clin Dermatol. 2017 Apr;18(2):215-230. doi: 10.1007/s40257-016-0239-8. Review.

Facial hyperpigmentation in darker skin types: Part 2.
Bala HR, Rodrigues M.
Dermatology in Practice. 2016 Winter;22(4):105-108. Review.

Energy-based device treatment of melasma: An update and review of the literature.
Dunbar S, Posnick D, Bloom B, Elias C, Zito P, Goldberg DJ.
J Cosmet Laser Ther. 2017 Feb;19(1):2-12. doi: 10.1080/14764172.2016.1229485. Review.

Skin hyperpigmentation in Indian population: Insights and best practice.
Nouveau S, Agrawal D, Kohli M, Bernerd F, Misra N, Nayak CS.Indian J Dermatol. 2016 Sep-Oct;61(5):487-95. doi: 10.4103/0019-5154.190103. Review.

Facial hyperpigmentation in darker skin types: Part 1.
Bala HR, Rodrigues M.
Dermatology in Practice. 2016 Autumn;22(3):79-82. Review.

Practice and educational gaps in abnormal pigmentation.
Mohammad TF, Hamzavi IH.
Dermatol Clin. 2016 Jul;34(3):291-301. doi: 10.1016/j.det.2016.02.005. Review.

Heterogeneous pathology of melasma and its clinical implications.
Kwon SH, Hwang YJ, Lee SK, Park KC.
Int J Mol Sci. 2016 May 26;17(6). pii: E824. doi: 10.3390/ijms17060824. Review.

Melasma and post inflammatory hyperpigmentation: management update and expert opinion.
Sofen B, Prado G, Emer J.
Skin Therapy Lett. 2016 Jan;21(1):1-7. Review.

Recent progress in melasma pathogenesis. 
Lee AY.
Pigment Cell Melanoma Res. 2015 Nov;28(6):648-60. doi: 10.1111/pcmr.12404. Epub 2015 Sep 8. Review.

Melasma: clinical diagnosis and management options. 
Rodrigues M, Pandya AG.
Australas J Dermatol. 2015 Aug;56(3):151-63. doi: 10.1111/ajd.12290. Epub 2015 Mar 9. Review. 

Melasma update. 
Sarkar R, Arora P, Garg VK, Sonthalia S, Gokhale N.
Indian Dermatol Online J. 2014 Oct;5(4):426-35. doi: 10.4103/2229-5178.142484. Review.

Melasma: a clinical and epidemiological review. 
Handel AC, Miot LD, Miot HA.
An Bras Dermatol. 2014 Sep-Oct;89(5):771-82. Review.

Polypodium leucotomos as an adjunct treatment of pigmentary disorders. 
Nestor M, Bucay V, Callender V, Cohen JL, Sadick N, Waldorf H.
J Clin Aesthet Dermatol. 2014 Mar;7(3):13-7. Review.

The use of ablative lasers in the treatment of facial melasma. 
Morais OO, Lemos ÉF, Sousa MC, Gomes CM, Costa IM, Paula CD.
An Bras Dermatol. 2013 Mar-Apr;88(2):238-42. doi: 10.1590/S0365-05962013000200009. Review.

Tranexamic acid: an important adjuvant in the treatment of melasma. 
Tse TW, Hui E.
J Cosmet Dermatol. 2013 Mar;12(1):57-66. doi: 10.1111/jocd.12026. Review.

Melasma pathogenesis and influencing factors - an overview of the latest research. 
Passeron T.
J Eur Acad Dermatol Venereol. 2013 Jan;27 Suppl 1:5-6. doi: 10.1111/jdv.12049. Review.

Treatment of melasma and the use of intense pulsed light: a review. 
Zaleski L, Fabi S, Goldman MP.
J Drugs Dermatol. 2012 Nov;11(11):1316-20. Review.

[Melasma and aspects of pigmentary disorders in Asians]. 
Kang HY.
Ann Dermatol Venereol. 2012 Nov;139 Suppl 3:S92-5. doi: 10.1016/S0151-9638(12)70117-5. Review. French. 

Melasma. 
Wu IB, Lambert C, Lotti TM, Hercogová J, Sintim-Damoa A, Schwartz RA.
G Ital Dermatol Venereol. 2012 Aug;147(4):413-8. Review.

Newer and upcoming therapies for melasma. 
Sarkar R, Chugh S, Garg VK.
Indian J Dermatol Venereol Leprol. 2012 Jul-Aug;78(4):417-28. doi: 10.4103/0378-6323.98071. Review.

Advances in the treatment of melasma: a review of the recent literature. 
Ball Arefiev KL, Hantash BM.
Dermatol Surg. 2012 Jul;38(7 Pt 1):971-84. doi: 10.1111/j.1524-4725.2012.02435.x. Epub 2012 May 14. Review.

The evolution of melasma therapy: targeting melanosomes using low-fluence Q-switched neodymium-doped yttrium aluminium garnet lasers. 
Kauvar AN.
Semin Cutan Med Surg. 2012 Jun;31(2):126-32. doi: 10.1016/j.sder.2012.02.002. Review.

Melasma in men. 
Vachiramon V, Suchonwanit P, Thadanipon K.
J Cosmet Dermatol. 2012 Jun;11(2):151-7. doi: 10.1111/j.1473-2165.2012.00613.x. Review.

Lasers for treatment of melasma and post-inflammatory hyperpigmentation. 
Arora P, Sarkar R, Garg VK, Arya L.
J Cutan Aesthet Surg. 2012 Apr;5(2):93-103. doi: 10.4103/0974-2077.99436. Review.

Melasma: treatment strategy. 
Sehgal VN, Verma P, Srivastava G, Aggarwal AK, Verma S.
J Cosmet Laser Ther. 2011 Dec;13(6):265-79. doi: 10.3109/14764172.2011.630088. Review.

Melasma: a comprehensive update: part I. 
Sheth VM, Pandya AG.
J Am Acad Dermatol. 2011 Oct;65(4):689-97; quiz 698. doi: 10.1016/j.jaad.2010.12.046. Review.

Melasma: a comprehensive update: part II. 
Sheth VM, Pandya AG.
J Am Acad Dermatol. 2011 Oct;65(4):699-714; quiz 715. doi: 10.1016/j.jaad.2011.06.001. Review.

Melasma--updated treatments. 
Situm M, Kolić M, Bolanca Z, Ljubicić I, Misanović B.
Coll Antropol. 2011 Sep;35 Suppl 2:315-8. Review.

Topical retinoids for pigmented skin. 
Geria AN, Lawson CN, Halder RM.
J Drugs Dermatol. 2011 May;10(5):483-9. Review.

[Is there any place for laser devices in the treatment of melasma?]. 
Badri T, Hammami H, Benmously R, Mokhtar I, Fenniche S.
Ann Dermatol Venereol. 2011;138(4):319-20. doi: 10.1016/j.annder.2010.12.016. Epub 2011 Feb 1. Review. French. No abstract available.

Melasma: insights and perspectives. 
Jadotte YT, Schwartz RA.
Acta Dermatovenerol Croat. 2010;18(2):124-9. Review.

Melasma update. 
Young Kang H, Ortonne JP.
Actas Dermosifiliogr. 2009 Dec;100 Suppl 2:110-3. Review.

[Physiopathology of melasma]. 
Miot LD, Miot HA, Silva MG, Marques ME.
An Bras Dermatol. 2009 Nov-Dec;84(6):623-35. Review. Portuguese.

Melasma in Latin America: options for therapy and treatment algorithm. 
Cestari T, Arellano I, Hexsel D, Ortonne JP; Latin American Pigmentary Disorders Academy. 
J Eur Acad Dermatol Venereol. 2009 Jul;23(7):760-72. doi: 10.1111/j.1468-3083.2009.03251.x. Review.

Hyperpigmentation and melasma. 
Rigopoulos D, Gregoriou S, Katsambas A.
J Cosmet Dermatol. 2007 Sep;6(3):195-202. Review. 

Melasma and its impact on health-related quality of life in Hispanic women. 
Pawaskar MD, Parikh P, Markowski T, McMichael AJ, Feldman SR, Balkrishnan R.
J Dermatolog Treat. 2007;18(1):5-9. Review.

Origin, clinical presentation, and diagnosis of facial hypermelanoses. 
Nicolaidou E, Antoniou C, Katsambas AD.
Dermatol Clin. 2007 Jul;25(3):321-6, viii. Review.

The treatment of melasma: a review of clinical trials. 
Gupta AK, Gover MD, Nouri K, Taylor S.
J Am Acad Dermatol. 2006 Dec;55(6):1048-65. Epub 2006 Sep 28. Review.

Topical treatments for melasma and postinflammatory hyperpigmentation. 
Lynde CB, Kraft JN, Lynde CW.
Skin Therapy Lett. 2006 Nov;11(9):1-6. Review.

Treatment of melasma. 
Rendon M, Berneburg M, Arellano I, Picardo M.
J Am Acad Dermatol. 2006 May;54(5 Suppl 2):S272-81. Review.

A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream. 
Torok HM.
Am J Clin Dermatol. 2006;7(4):223-30. Review.

A practical comparison of hydroquinone-containing products for the treatment of melasma. 
Abramovits W, Barzin S, Arrazola P.
Skinmed. 2005 Nov-Dec;4(6):371-6. Review. No abstract available. 

Can you identify this condition? Melasma. 
Ting PT, Barankin B.
Can Fam Physician. 2005 Mar;51:353-5. Review. No abstract available.

Melasma: a review. 
Victor FC, Gelber J, Rao B.
J Cutan Med Surg. 2004 Mar-Apr;8(2):97-102. Epub 2004 May 4. Review.

Melasma of the forearms. 
O'Brien TJ, Dyall-Smith D, Hall AP.
Australas J Dermatol. 1997 Feb;38(1):35-7. Review.

Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies. 
Breathnach AS.
Cutis. 1996 Jan;57(1 Suppl):36-45. Review.

Melasma. Etiologic and therapeutic considerations. 
Grimes PE.
Arch Dermatol. 1995 Dec;131(12):1453-7. Review.

 

Back to index page